Komori
Financial results presentation9218Mental Health Technologies Co.,Ltd.Information and Communications, Services and Others

Financial Results Presentation for the First Quarter of the Fiscal Year Ending December 2026

Revenue increased year on year in the first quarter, while operating profit, ordinary profit and net income declined. The MHS business exceeded plan in both revenue and profit, while profit in the MWS business fell below plan as upfront investments and improved employee benefits reduced its profit margin.

Worth reading
81Important
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
294
¥ million (year-on-year increase in consolidated net sales)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFirst quarter of the fiscal year ending December 202610 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,747 million+20.3%
Operating profit¥107 million-16.2%
Ordinary income¥94 million-20.7%
Net income¥54 million-22.1%
Operating profit margin6.2 %
Results for the three months of the current quarterRevenue: ¥1,747 million; operating profit: ¥107 million; adjusted operating profit: ¥142 million; ordinary profit: ¥94 million; net income attributable to owners of the parent: ¥54 million
Full-year earnings forecast
Net Sales
¥9,252 million
Operating profit
¥700 million
Adjusted operating profit
¥878 million
Ordinary income
¥528 million
Profit attributable to owners of the parent
¥286 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Consolidated revenue18.9 %
Operating profit15.3 %
MHS business (occupational health) operating profit23.7 %
MHS business (return-to-work) operating profit0 %
MWS business operating profit19.8 %
Other Businesses operating income15.3 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue and operating profit came in as planned. The MHS business exceeded plan in both revenue and profit, while profit in the MWS business fell below plan
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Increase in MHS business revenue¥114 million
  • Increase in MWS business revenue¥195 million
  • Decrease in MWS business profit¥-9 million
  • Decrease in Other business profit¥-9 million
  • Due diligence costs associated with making インクルード社 a subsidiary¥-20 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • Medical fee revision effective 1 June 20262.22 % increase
  • Number of people the MWS business can hire40–50 per month
New initiatives
  • Fundamental overhaul of the sales structure, with new customer acquisition and upselling as the top priorities
  • Collaboration and upselling involving インクルード社's return-to-work support services
  • Development of a dedicated application to visualize the workload and productivity of nursing assistants
  • In-house development and pilot introduction of an application for quantitative personnel evaluations of frontline staff
  • Establishment of the Japan Nursing Assistants Association
  • Opening of the Fukuoka office
  • Initiatives to obtain the Medical Services Mark
Key KPIsA metric the company considers important as a management benchmark.
  • MRR（ENT）¥146 million
    Year on year against the same period last year+17.7%
  • MRR（SMB）¥83 million
    Year on year against the same period last year+10.7%
  • Number of ENT contract groups238 Group
    Year on year against the same period last year+27.3%
  • Number of SMB contracted companies2,068 companies
    Year on year against the same period last year+10.4%
  • NRR119.6 %
    Year on year against the same period last year+14.3%
  • Average monthly ENT churn rate0 %
    Year on year against the same period last year-0.2%
  • Average monthly SMB churn rate0.3 %
    Year on year against the same period last year0.0%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
  • ENT contract unit price¥638 thousand/company
    Year on year against the same period last year-7.3%
  • SMB contract unit price¥46 thousand/company
    Year on year against the same period last year0.0%
  • Number of ENT contract groups238 Group
    Year on year against the same period last year+27.3%
  • Number of SMB contracted companies2,068 companies
    Year on year against the same period last year+10.4%
Segment results
MHS business
Net Sales
¥822 million+16.2%
Profit
¥238 million+17.9%
Operating margin
29 %
MWS Business
Net Sales
¥906 million+27.6%
Profit
¥57 million-14.8%
Operating margin
6.3 %
yoy_change_points-3.1
Other Businesses
Net Sales
¥18 million-45.8%
Profit
¥-6 million
Orders received and order backlog
Orders secured exceed the full-year budget. The amount is Not disclosed
Number of stores and locations
A Fukuoka office was newly established. The number of locations at period-end and the number of openings and closures during the period are Not disclosed
Number of employees
1,329 People as of March 2026, consolidated
Hiring planRecruitment continues in the MHS business, MWS business and corporate functions. The MWS business has a structure capable of hiring 40–50 people per month
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFirst quarter of the fiscal year ending December 2026
Net Sales¥1,747 million (YoY +20.3%)
Operating profit¥107 million (YoY -16.2%)
Ordinary income¥94 million (YoY -20.7%)
Net income¥54 million (YoY -22.1%)
Operating profit margin6.2 %
Results for the three months of the current quarterRevenue: ¥1,747 million; operating profit: ¥107 million; adjusted operating profit: ¥142 million; ordinary profit: ¥94 million; net income attributable to owners of the parent: ¥54 million
Full-year earnings forecastNet Sales ¥9,252 million / Operating profit ¥700 million / Adjusted operating profit ¥878 million / Ordinary income ¥528 million / Profit attributable to owners of the parent ¥286 million
Progress against full-year forecastConsolidated revenue 18.9 % / Operating profit 15.3 % / MHS business (occupational health) operating profit 23.7 % / MHS business (return-to-work) operating profit 0 % / MWS business operating profit 19.8 % / Other Businesses operating income 15.3 %
Self-assessment against the planRevenue and operating profit came in as planned. The MHS business exceeded plan in both revenue and profit, while profit in the MWS business fell below plan
Segment resultsMHS business Net Sales ¥822 million (YoY +16.2%) / Profit ¥238 million (YoY +17.9%) / Operating margin 29 % / MWS Business Net Sales ¥906 million (YoY +27.6%) / Profit ¥57 million (YoY -14.8%) / Operating margin 6.3 % / Other Businesses Net Sales ¥18 million (YoY -45.8%) / Profit ¥-6 million
Breakdown of Factors Affecting the ChangeFactors Increase in MHS business revenue / Amount ¥114 million, Factors Increase in MWS business revenue / Amount ¥195 million, Factors Decrease in MWS business profit / Amount ¥-9 million, Factors Decrease in Other business profit / Amount ¥-9 million, Factors Due diligence costs associated with making インクルード社 a subsidiary / Amount ¥-20 million
Key KPIsIndicator name MRR（ENT） / Value ¥146 million / Year on year against the same period last year ¥17.7 million, Indicator name MRR（SMB） / Value ¥83 million / Year on year against the same period last year ¥10.7 million, Indicator name Number of ENT contract groups / Value 238 Group / Year on year against the same period last year 27.3 Group, Indicator name Number of SMB contracted companies / Value 2,068 companies / Year on year against the same period last year 10.4 companies, Indicator name NRR / Value 119.6 % / Year on year against the same period last year 14.3 %, Indicator name Average monthly ENT churn rate / Value 0 % / Year on year against the same period last year -0.2 %, Indicator name Average monthly SMB churn rate / Value 0.3 % / Year on year against the same period last year 0 %
Unit price and quantity metricsIndicator name ENT contract unit price / Value ¥638 thousand/company / Year on year against the same period last year ¥-7.3 thousand/company, Indicator name SMB contract unit price / Value ¥46 thousand/company / Year on year against the same period last year ¥0 thousand/company, Indicator name Number of ENT contract groups / Value 238 Group / Year on year against the same period last year 27.3 Group, Indicator name Number of SMB contracted companies / Value 2,068 companies / Year on year against the same period last year 10.4 companies
Number of stores and locationsA Fukuoka office was newly established. The number of locations at period-end and the number of openings and closures during the period are Not disclosed
Number of employees1,329 People (as of March 2026, consolidated)
Assumptions Underlying the Business OutlookItem Medical fee revision effective 1 June 2026 / Value 2.22 % increase, Item Number of people the MWS business can hire / Value 40–50 per month
Orders received and order backlogOrders secured exceed the full-year budget. The amount is Not disclosed
New initiativesFundamental overhaul of the sales structure, with new customer acquisition and upselling as the top priorities, Collaboration and upselling involving インクルード社's return-to-work support services, Development of a dedicated application to visualize the workload and productivity of nursing assistants, In-house development and pilot introduction of an application for quantitative personnel evaluations of frontline staff, Establishment of the Japan Nursing Assistants Association, Opening of the Fukuoka office, Initiatives to obtain the Medical Services Mark
Items this document does not state (11)
Gross Profit MarginSelling, general and administrative expensesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased due to new customer acquisition and upselling in the MHS business and new project wins in the MWS business. On the profit side, upfront investment related to large projects in the MWS business, improved compensation aimed at retaining and securing personnel, and approximately ¥20 million in due diligence costs associated with making インクルード社 a subsidiary weighed on earnings.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the First Quarter of the Fiscal Year Ending December 2026 | Mental Health Technologies Co.,Ltd. (9218) timely disclosure | Komori